Yatsen Announces Fourth Quarter and Full Year 2023 Financial Results
- Total net revenues increased by 6.7% to RMB1.07 billion in Q4 2023.
- Total net revenues decreased by 7.9% to RMB3.41 billion for the full year 2023.
- Net revenues from Skincare Brands increased significantly in Q4 and full year 2023.
- Gross margin improved to 73.7% in Q4 2023.
- Net loss increased in Q4 but decreased for the full year 2023.
- Non-GAAP net loss narrowed in Q4 and full year 2023.
- Company focuses on sustainable growth and innovation across its brands.
- Net loss for Q4 increased significantly.
- Total net revenues decreased for the full year 2023.
- Operating expenses increased by 67.7% in Q4 2023.
- Impairment of goodwill recorded in Q4 2023.
- Loss from operations increased in Q4 2023.
- Net cash used in operating activities for the full year 2023.
- Company's total net revenues forecast for Q1 2024 shows minimal growth.
Insights
Analyzing the financial results of Yatsen Holding Limited, the increase in net revenues for Q4 2023 by 6.7% indicates a positive market response to the company's strategic transformations and product offerings, particularly in the skincare segment which saw a significant 17.6% increase. This growth trajectory, driven by key brands such as Galénic, DR.WU and Eve Lom, is a testament to the company's ability to adapt and innovate within the dynamic beauty industry. The emphasis on skincare over color cosmetics aligns with broader market trends that prioritize skincare due to its perceived long-term benefits and higher customer loyalty.
However, the overall decrease in total net revenues for the full year of 2023 by 7.9% raises concerns about the sustainability of growth and the company's performance in the color cosmetics segment. This may reflect shifting consumer preferences or increased competition in the market. Investors would be keen to monitor how Yatsen's repositioning efforts for its Perfect Diary brand will influence future revenue streams, especially considering the brand's recent success in the lipstick category.
The reported gross margin improvement from 68.0% to 73.6% for the full year indicates a strong pricing strategy and cost management. Yatsen's focus on higher-margin skincare products and disciplined pricing could lead to improved profitability in the long term. However, the significant net loss reported for both Q4 and the full year, with a substantial goodwill impairment charge related to the Eve Lom brand, suggests potential overvaluation of acquired assets or underperformance post-acquisition.
From a financial health perspective, the company's cash, restricted cash and short-term investments of RMB2.08 billion provide a buffer for strategic initiatives. Yet, the increase in operating expenses, particularly in selling and marketing, which rose to 66.9% of total net revenues for Q4, may be a cause for concern as it outpaces revenue growth and could strain future earnings if not managed effectively.
The goodwill impairment of RMB354.0 million recorded for the Eve Lom reporting unit is a critical financial event that reflects management's reassessment of the brand's future earning potential. This impairment indicates that the fair value of the brand has decreased below its carrying amount on the balance sheet, which may be attributed to weaker than expected operating results. Such impairments are closely scrutinized by regulatory bodies for compliance with accounting standards and to ensure that investors receive a transparent picture of a company's financial health.
Additionally, the use of non-GAAP measures like non-GAAP net loss and non-GAAP loss from operations is a common practice to provide a clearer view of a company's operational performance by excluding non-recurring or non-cash expenses. However, it is important for investors to understand these adjustments and consider both GAAP and non-GAAP measures when evaluating the company's financial position.
Conference Call to Be Held at 7:30 A.M.
Fourth Quarter and Full Year 2023 Highlights
- Total net revenues for the fourth quarter of 2023 increased by
6.7% toRMB1.07 billion (US ) from$151.1 million RMB1.01 billion for the prior year period. Total net revenues for the full year of 2023 decreased by7.9% toRMB3 .41 billion (US .0 million) from RMB3.71 billion for the prior year period.$481 - Total net revenues from Skincare Brands[1] for the fourth quarter of 2023 increased by
17.6% toRMB554.8 million (US ) from$78.1 million RMB471.6 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the fourth quarter of 2023 increased to51.7% from46.9% for the prior year period. Total net revenues from Skincare Brands for the full year of 2023 increased by11.4% toRMB1.38 billion (US ) from$194.9 million RMB1.24 billion for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the full year of 2023 increased to40.5% from33.5% for the prior year period. - Gross margin for the fourth quarter of 2023 was
73.7% , as compared with71.1% for the prior year period. Gross margin for the full year of 2023 was73.6% , as compared with68.0% for the prior year period. - Net loss for the fourth quarter of 2023 was
RMB494.5 million (US ), as compared with$69.7 million RMB55.0 million for the prior year period. Net loss for the full year of 2023 decreased by8.7% toRMB750.2 million (US ) from$105.7 million RMB821.3 million for the prior year period. Non-GAAP net loss[2] for the fourth quarter of 2023 wasRMB93.7 million (US ), as compared with non-GAAP net income of$13.2 million RMB34.7 million for the prior year period. Non-GAAP net loss for the full year of 2023 decreased by34.6% toRMB296.1 million (US ) from$41.7 million RMB452.9 million for the prior year period.
Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "We were pleased to return to a growth trajectory in the fourth quarter of 2023 as we made further progress on our strategic transformation plan. Driven by solid performances from Galénic, DR.WU and Eve Lom, revenues from our Skincare Brands increased by
Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "We recorded a year-over-year increase of
Fourth Quarter 2023 Financial Results
Net Revenues
Total net revenues for the fourth quarter of 2023 increased by
Gross Profit and Gross Margin
Gross profit for the fourth quarter of 2023 increased by
Operating Expenses
Total operating expenses for the fourth quarter of 2023 increased by
- Fulfillment Expenses. Fulfillment expenses for the fourth quarter of 2023 were
RMB62.7 million (US ), as compared with$8.8 million RMB62.5 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the fourth quarter of 2023 decreased to5.8% from6.2% for the prior year period. The decrease was primarily attributable to further improvements in logistics efficiency. - Selling and Marketing Expenses. Selling and marketing expenses for the fourth quarter of 2023 were
RMB717.4 million (US ), as compared with$101.0 million RMB535.2 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the fourth quarter of 2023 increased to66.9% from53.2% for the prior year period. The increase was primarily due to the Perfect Diary brand upgrade as well as the Company's investments in new product launches across its brands. - General and Administrative Expenses. General and administrative expenses for the fourth quarter of 2023 were
RMB158.7 million (US ), as compared with$22.4 million RMB169.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the fourth quarter of 2023 decreased to14.8% from16.9% for the prior year period. The decrease was primarily attributable to a reduction in share-based compensation. - Research and Development Expenses. Research and development expenses for the fourth quarter of 2023 were
RMB36.9 million (US ), as compared with$5.2 million RMB25.1 million for the prior year period. As a percentage of total net revenues, research and development expenses for the fourth quarter of 2023 increased to3.4% from2.5% for the prior year period. The increase was primarily attributable to an increase in personnel costs, reflecting the Company's commitment to enhancing its research and development capabilities. - Impairment of Goodwill. Impairment of goodwill for the fourth quarter of 2023 was
RMB354.0 million (US ), as compared with nil in the prior year period. Impairment recorded in this quarter represents the amount by which the carrying value of the Eve Lom reporting unit exceeded its fair value, based on quantitative goodwill impairment test, primarily due to weaker operating results than expected at the time of acquisition.$49.9 million
Loss from Operations
Loss from operations for the fourth quarter of 2023 was
Non-GAAP loss from operations[4] for the fourth quarter of 2023 was
Net Loss
Net loss for the fourth quarter of 2023 was
Non-GAAP net loss for the fourth quarter of 2023 was
Full Year 2023 Financial Results
Total net revenues for the full year of 2023 decreased by
Gross profit for the full year of 2023 decreased by
Loss from operations for the full year of 2023 was
Non-GAAP loss from operations for the full year of 2023 was
Net loss for the full year of 2023 was
Non-GAAP net loss for the full year of 2023 was
Balance Sheet and Cash Flow
As of December 31, 2023, the Company had cash, restricted cash and short-term investments of
Net cash generated from operating activities for the fourth quarter of 2023 was
Business Outlook
For the first quarter of 2024, the Company expects its total net revenues to be between
Exchange Rate
This announcement contains translations of certain Renminbi ("RMB") amounts into
[1] Include net revenues from Galénic, DR.WU (its mainland |
[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Effective from the fourth quarter of 2023, non-GAAP net income (loss) is defined as net loss excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill and (v) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) for the prior year period presented in this document is also calculated in the same manner. |
[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company. |
[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Effective from the fourth quarter of 2023, non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP income (loss) from operations for the prior year period presented in this document is also calculated in the same manner. |
[5] ADS refers to American depositary shares, each of which represents four Class A ordinary shares. |
[6] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Effective from the fourth quarter of 2023, non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) tax effects on non-GAAP adjustments and (vi) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS for the prior year period presented in this document is also calculated in the same manner. |
Conference Call Information
The Company's management will hold a conference call on Wednesday, March 6, 2024, at 7:30 A.M.
+1-888-346-8982 | |
International: | +1-412-902-4272 |
Mainland | 400-120-1203 |
800-905-945 | |
+852-3018-4992 | |
Conference ID: | 8685896 |
The replay will be accessible through March 13, 2024, by dialing the following numbers:
United States: | +1-877-344-7529 |
International: | +1-412-317-0088 |
Replay Access Code: | 8685896 |
A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com/.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading
For more information, please visit http://ir.yatsenglobal.com/.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP income (loss) from operations, non-GAAP net income (loss), non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with
However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the
For investor and media inquiries, please contact:
In
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com
Piacente Financial Communications
Hui Fan
Tel: +86-10-6508-0677
E-mail: yatsen@thepiacentegroup.com
In
Piacente Financial Communications
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yatsen@thepiacentegroup.com
YATSEN HOLDING LIMITED | ||||||||||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||||
(All amounts in thousands, except for share, per share data or otherwise noted) | ||||||||||||
December 31, | December 31, | December 31, | ||||||||||
2022 | 2023 | 2023 | ||||||||||
RMB'000 | RMB'000 | USD'000 | ||||||||||
Assets | ||||||||||||
Current assets | ||||||||||||
Cash and cash equivalents | 1,512,945 | 836,888 | 117,873 | |||||||||
Restricted Cash | - | 21,248 | 2,993 | |||||||||
Short-term investments | 1,072,867 | 1,218,481 | 171,619 | |||||||||
Accounts receivable, net | 200,843 | 198,851 | 28,008 | |||||||||
Inventories, net | 423,287 | 352,090 | 49,591 | |||||||||
Prepayments and other current assets | 292,825 | 303,841 | 42,795 | |||||||||
Amounts due from related parties | 5,654 | 20,200 | 2,845 | |||||||||
Total current assets | 3,508,421 | 2,951,599 | 415,724 | |||||||||
Non-current assets | ||||||||||||
Restricted cash | 41,383 | - | - | |||||||||
Investments | 502,579 | 618,752 | 87,149 | |||||||||
Property and equipment, net | 75,619 | 64,878 | 9,138 | |||||||||
Goodwill, net | 857,145 | 556,567 | 78,391 | |||||||||
Intangible assets, net | 689,669 | 671,396 | 94,564 | |||||||||
Deferred tax assets | 1,951 | 1,375 | 194 | |||||||||
Right-of-use assets, net | 133,004 | 114,348 | 16,106 | |||||||||
Other non-current assets | 52,885 | 27,100 | 3,817 | |||||||||
Total non-current assets | 2,354,235 | 2,054,416 | 289,359 | |||||||||
Total assets | 5,862,656 | 5,006,015 | 705,083 | |||||||||
Liabilities, redeemable non-controlling interests and shareholders' equity | ||||||||||||
Current liabilities | ||||||||||||
Accounts payable | 119,847 | 105,691 | 14,886 | |||||||||
Advances from customers | 16,652 | 41,579 | 5,856 | |||||||||
Accrued expenses and other liabilities | 323,259 | 391,217 | 55,102 | |||||||||
Amounts due to related parties | 27,242 | 9,431 | 1,328 | |||||||||
Income tax payables | 21,826 | 17,946 | 2,528 | |||||||||
Lease liabilities due within one year | 79,586 | 45,464 | 6,403 | |||||||||
Total current liabilities | 588,412 | 611,328 | 86,103 | |||||||||
Non-current liabilities | ||||||||||||
Deferred tax liabilities | 113,441 | 111,591 | 15,717 | |||||||||
Deferred income-non current | 45,280 | 30,556 | 4,304 | |||||||||
Lease liabilities | 52,997 | 67,767 | 9,545 | |||||||||
Total non-current liabilities | 211,718 | 209,914 | 29,566 | |||||||||
Total liabilities | 800,130 | 821,242 | 115,669 | |||||||||
Redeemable non-controlling interests | 339,924 | 51,466 | 7,249 | |||||||||
Shareholders' equity | ||||||||||||
Ordinary Shares ( | 173 | 173 | 24 | |||||||||
Treasury shares | (669,150) | (864,568) | (121,772) | |||||||||
Additional paid-in capital | 12,038,802 | 12,260,208 | 1,726,814 | |||||||||
Statutory reserve | 24,177 | 24,177 | 3,405 | |||||||||
Accumulated deficit | (6,600,365) | (7,345,153) | (1,034,543) | |||||||||
Accumulated other comprehensive (loss) income | (74,195) | 60,200 | 8,481 | |||||||||
Total Yatsen Holding Limited shareholders' equity | 4,719,442 | 4,135,037 | 582,409 | |||||||||
Non-controlling interests | 3,160 | (1,730) | (244) | |||||||||
Total shareholders' equity | 4,722,602 | 4,133,307 | 582,165 | |||||||||
Total liabilities, redeemable non-controlling interests and shareholders' equity | 5,862,656 | 5,006,015 | 705,083 |
YATSEN HOLDING LIMITED | ||||||||||||||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||||||||
(All amounts in thousands, except for share, per share data or otherwise noted) | ||||||||||||||||||||||||
For the Three Months Ended December 31, | For the Year Ended December 31, | |||||||||||||||||||||||
2022 | 2023 | 2023 | 2022 | 2023 | 2023 | |||||||||||||||||||
RMB'000 | RMB'000 | USD'000 | RMB'000 | RMB'000 | USD'000 | |||||||||||||||||||
Total net revenues | 1,005,494 | 1,072,691 | 151,085 | 3,706,122 | 3,414,774 | 480,961 | ||||||||||||||||||
Total cost of revenues | (290,886) | (282,548) | (39,796) | (1,187,370) | (901,455) | (126,967) | ||||||||||||||||||
Gross profit | 714,608 | 790,143 | 111,289 | 2,518,752 | 2,513,319 | 353,994 | ||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||
Fulfilment expenses | (62,523) | (62,741) | (8,837) | (269,886) | (229,021) | (32,257) | ||||||||||||||||||
Selling and marketing expenses | (535,244) | (717,439) | (101,049) | (2,330,480) | (2,230,974) | (314,226) | ||||||||||||||||||
General and administrative expenses | (169,945) | (158,716) | (22,355) | (720,409) | (500,942) | (70,556) | ||||||||||||||||||
Research and development expenses | (25,139) | (36,851) | (5,190) | (126,875) | (111,698) | (15,732) | ||||||||||||||||||
Impairment of goodwill | - | (354,039) | (49,865) | - | (354,039) | (49,865) | ||||||||||||||||||
Total operating expenses | (792,851) | (1,329,786) | (187,296) | (3,447,650) | (3,426,674) | (482,636) | ||||||||||||||||||
Loss from operations | (78,243) | (539,643) | (76,007) | (928,898) | (913,355) | (128,642) | ||||||||||||||||||
Financial income | 7,456 | 15,763 | 2,220 | 34,656 | 89,020 | 12,538 | ||||||||||||||||||
Foreign currency exchange gain (loss) | 8,380 | 6,400 | 901 | (35,357) | 7,218 | 1,017 | ||||||||||||||||||
(Loss) income from equity method investments, net | (2,086) | 4,446 | 626 | 12,548 | 10,122 | 1,426 | ||||||||||||||||||
Impairment of investments | - | - | - | (5,078) | - | - | ||||||||||||||||||
Other income, net | 7,717 | 15,612 | 2,199 | 103,501 | 53,558 | 7,543 | ||||||||||||||||||
Loss before income tax expenses | (56,776) | (497,422) | (70,061) | (818,628) | (753,437) | (106,118) | ||||||||||||||||||
Income tax benefits (expenses) | 1,823 | 2,896 | 408 | (2,705) | 3,210 | 452 | ||||||||||||||||||
Net loss | (54,953) | (494,526) | (69,653) | (821,333) | (750,227) | (105,666) | ||||||||||||||||||
Net loss attributable to non-controlling interests and redeemable non-controlling interests | 2,705 | 4,011 | 565 | 5,962 | 5,439 | 766 | ||||||||||||||||||
Accretion to redeemable non-controlling interests | - | - | - | - | (2,975) | (419) | ||||||||||||||||||
Net loss attributable to Yatsen's shareholders | (52,248) | (490,515) | (69,088) | (815,371) | (747,763) | (105,319) | ||||||||||||||||||
Shares used in calculating loss per share (1): | ||||||||||||||||||||||||
Weighted average number of Class A | ||||||||||||||||||||||||
Basic | 2,236,277,374 | 2,146,881,745 | 2,146,881,745 | 2,372,728,777 | 2,195,818,231 | 2,195,818,231 | ||||||||||||||||||
Diluted | 2,236,277,374 | 2,146,881,745 | 2,146,881,745 | 2,372,728,777 | 2,195,818,231 | 2,195,818,231 | ||||||||||||||||||
Net loss per Class A and Class B | ||||||||||||||||||||||||
Basic | (0.02) | (0.23) | (0.03) | (0.34) | (0.34) | (0.05) | ||||||||||||||||||
Diluted | (0.02) | (0.23) | (0.03) | (0.34) | (0.34) | (0.05) | ||||||||||||||||||
Net loss per ADS (4 ordinary shares | ||||||||||||||||||||||||
Basic | (0.09) | (0.91) | (0.13) | (1.37) | (1.36) | (0.19) | ||||||||||||||||||
Diluted | (0.09) | (0.91) | (0.13) | (1.37) | (1.36) | (0.19) |
For the Three Months Ended December 31, | For the Year Ended December 31, | |||||||||||||||||||||||
2022 | 2023 | 2023 | 2022 | 2023 | 2023 | |||||||||||||||||||
Share-based compensation expenses | RMB'000 | RMB'000 | USD'000 | RMB'000 | RMB'000 | USD'000 | ||||||||||||||||||
Fulfilment expenses | 937 | 256 | 36 | 4,267 | 2,055 | 289 | ||||||||||||||||||
Selling and marketing expenses | 13,712 | 3,298 | 465 | 62,231 | 23,518 | 3,312 | ||||||||||||||||||
General and administrative expenses | 57,586 | 39,688 | 5,590 | 248,400 | 46,902 | 6,606 | ||||||||||||||||||
Research and development expenses | 4,490 | 1,241 | 175 | 25,962 | 5,027 | 708 | ||||||||||||||||||
Total | 76,725 | 44,483 | 6,266 | 340,860 | 77,502 | 10,915 |
(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each |
YATSEN HOLDING LIMITED | ||||||||||||||||||||||||
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS | ||||||||||||||||||||||||
(All amounts in thousands, except for share, per share data or otherwise noted) | ||||||||||||||||||||||||
For the Three Months Ended December 31, | For the Year Ended December 31, | |||||||||||||||||||||||
2022 | 2023 | 2023 | 2022 | 2023 | 2023 | |||||||||||||||||||
RMB'000 | RMB'000 | USD'000 | RMB'000 | RMB'000 | USD'000 | |||||||||||||||||||
Loss from operations | (78,243) | (539,643) | (76,007) | (928,898) | (913,355) | (128,642) | ||||||||||||||||||
Share-based compensation expenses | 76,725 | 44,483 | 6,266 | 340,860 | 77,502 | 10,915 | ||||||||||||||||||
Impairment of goodwill | - | 354,039 | 49,865 | - | 354,039 | 49,865 | ||||||||||||||||||
Amortization of intangible assets | 13,063 | 15,231 | 2,145 | 48,700 | 54,297 | 7,648 | ||||||||||||||||||
Non-GAAP income (loss) from | 11,545 | (125,890) | (17,731) | (539,338) | (427,517) | (60,214) | ||||||||||||||||||
Net loss | (54,953) | (494,526) | (69,653) | (821,333) | (750,227) | (105,666) | ||||||||||||||||||
Share-based compensation expenses | 76,725 | 44,483 | 6,266 | 340,860 | 77,502 | 10,915 | ||||||||||||||||||
Impairment of goodwill | - | 354,039 | 49,865 | - | 354,039 | 49,865 | ||||||||||||||||||
Amortization of intangible assets | 13,063 | 15,231 | 2,145 | 48,700 | 54,297 | 7,648 | ||||||||||||||||||
Revaluation of investments on the | 2,071 | (10,337) | (1,456) | (12,779) | (22,324) | (3,144) | ||||||||||||||||||
Tax effects on non-GAAP adjustments | (2,229) | (2,635) | (371) | (8,360) | (9,356) | (1,318) | ||||||||||||||||||
Non-GAAP net income (loss) | 34,677 | (93,745) | (13,204) | (452,912) | (296,069) | (41,700) | ||||||||||||||||||
Net loss attributable to Yatsen's | (52,248) | (490,515) | (69,088) | (815,371) | (747,763) | (105,319) | ||||||||||||||||||
Share-based compensation expenses | 76,725 | 44,483 | 6,266 | 340,860 | 77,502 | 10,915 | ||||||||||||||||||
Impairment of goodwill | - | 354,039 | 49,865 | - | 354,039 | 49,865 | ||||||||||||||||||
Amortization of intangible assets | 12,780 | 14,945 | 2,105 | 47,663 | 53,214 | 7,495 | ||||||||||||||||||
Revaluation of investments on the | 2,071 | (10,337) | (1,456) | (12,779) | (22,324) | (3,144) | ||||||||||||||||||
Tax effects on non-GAAP adjustments | (2,229) | (2,635) | (371) | (8,360) | (9,356) | (1,318) | ||||||||||||||||||
Accretion to redeemable non- | - | - | - | - | 2,975 | 419 | ||||||||||||||||||
Non-GAAP net income (loss) | 37,099 | (90,020) | (12,679) | (447,987) | (291,713) | (41,087) | ||||||||||||||||||
Shares used in calculating loss per | ||||||||||||||||||||||||
Weighted average number of Class A | ||||||||||||||||||||||||
Basic | 2,236,277,374 | 2,146,881,745 | 2,146,881,745 | 2,372,728,777 | 2,195,818,231 | 2,195,818,231 | ||||||||||||||||||
Diluted | 2,343,024,839 | 2,146,881,745 | 2,146,881,745 | 2,372,728,777 | 2,195,818,231 | 2,195,818,231 | ||||||||||||||||||
Non-GAAP net income (loss) | ||||||||||||||||||||||||
Basic | 0.02 | (0.04) | (0.01) | (0.19) | (0.13) | (0.02) | ||||||||||||||||||
Diluted | 0.02 | (0.04) | (0.01) | (0.19) | (0.13) | (0.02) | ||||||||||||||||||
Non-GAAP net income (loss) | ||||||||||||||||||||||||
Basic | 0.07 | (0.17) | (0.02) | (0.76) | (0.53) | (0.07) | ||||||||||||||||||
Diluted | 0.06 | (0.17) | (0.02) | (0.76) | (0.53) | (0.07) |
View original content:https://www.prnewswire.com/news-releases/yatsen-announces-fourth-quarter-and-full-year-2023-financial-results-302081184.html
SOURCE Yatsen Holding Limited
FAQ
What was the percentage increase in total net revenues for Q4 2023?
How did total net revenues perform for the full year 2023?
What was the change in net revenues from Skincare Brands in Q4 2023?
What was the gross margin for Q4 2023?
How did the net loss change in Q4 2023?